DR YADAVA N PRACTICE — All Prescriptions & Medications — Page 6
Practice Code: F81211 | GRAYS, RM17 6SP
Showing results 251-300 of 442
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 41 | 2,450 | £207 | -41.2% ▼ | |
| Zonisamide | 40 | 10.9K | £11.8K | -8.3% ▼ |
| Coal tar | 40 | 9,600 | £203 | -45.1% ▼ |
| 40 | 780 | £767 | +132.3% ▲ | |
| Ursodeoxycholic acid | 39 | 9,600 | £1.1K | -41.1% ▼ |
| Methenamine hippurate | 39 | 2,340 | £542 | -57.1% ▼ |
| Fluticasone propionate (Nasal) | 39 | 148 | £381 | -73.2% ▼ |
| Adapalene and benzoyl peroxide | 39 | 2,025 | £884 | -27.0% ▼ |
| Theophylline | 38 | 2,184 | £1.1K | -54.6% ▼ |
| Combined ethinylestradiol 20mcg | 38 | 948 | £587 | -27.3% ▼ |
| Calcium carbonate | 38 | 2,508 | £218 | -42.3% ▼ |
| Rabeprazole sodium | 37 | 1,011 | £170 | -28.3% ▼ |
| Tamsulosin and dutasteride hydrochloride | 37 | 1,064 | £428 | +5.9% ▲ |
| Hydrocortisone | 36 | 733 | £218 | -52.6% ▼ |
| Metoprolol tartrate | 36 | 1,204 | £118 | -29.0% ▼ |
| Olmesartan medoxomil | 36 | 1,008 | £167 | -47.7% ▼ |
| Fluconazole | 36 | 239 | £96 | -53.4% ▼ |
| Olopatadine | 36 | 300 | £267 | -17.9% ▼ |
| Bumetanide | 35 | 1,638 | £153 | -87.2% ▼ |
| Ticagrelor | 35 | 1,960 | £1.9K | -58.8% ▼ |
| Clobazam | 35 | 1,494 | £167 | -46.9% ▼ |
| Progesterone | 35 | 2,094 | £376 | -91.6% ▼ |
| Goserelin acetate | 35 | 35 | £2.8K | -20.6% ▼ |
| Sodium feredetate | 35 | 16.8K | £478 | +22.2% ▲ |
| Ibuprofen | 35 | 2,624 | £68 | -71.3% ▼ |
| Mefenamic acid | 35 | 1,964 | £383 | -22.5% ▼ |
| 35 | 4,100 | £406 | -27.4% ▼ | |
| Insulin Lispro | 33 | 220 | £1.3K | -56.9% ▼ |
| Ivabradine | 32 | 2,072 | £518 | -66.3% ▼ |
| Dutasteride | 32 | 934 | £54 | -37.7% ▼ |
| Timolol and travoprost | 32 | 143 | £617 | -1.0% vs avg |
| Nortriptyline | 31 | 1,762 | £615 | -78.7% ▼ |
| Cefalexin | 31 | 652 | £68 | -73.3% ▼ |
| 31 | 31 | £131 | -39.6% ▼ | |
| Clomipramine hydrochloride | 30 | 2,548 | £592 | -28.8% ▼ |
| Colchicine | 30 | 1,627 | £32 | -61.5% ▼ |
| 30 | 5,460 | £9.7K | -38.4% ▼ | |
| Sodium picosulfate | 29 | 6,700 | £619 | -20.1% ▼ |
| Phenobarbital | 29 | 1,484 | £45 | -5.7% ▼ |
| Oxytetracycline | 29 | 2,548 | £1.0K | +12.3% ▲ |
| Erythromycin ethylsuccinate | 29 | 3,400 | £290 | +24.2% ▲ |
| Pioglitazone hydrochloride | 29 | 812 | £30 | -67.2% ▼ |
| Etoricoxib | 29 | 812 | £245 | -64.0% ▼ |
| Atomoxetine hydrochloride | 28 | 1,522 | £2.9K | -17.2% ▼ |
| Biphasic insulin aspart | 28 | 365 | £2.2K | -72.4% ▼ |
| Betamethasone esters | 28 | 2,290 | £217 | -53.6% ▼ |
| Meloxicam | 27 | 694 | £22 | -59.2% ▼ |
| Brinzolamide/brimonidine | 27 | 400 | £702 | -21.3% ▼ |
| Mupirocin | 27 | 1,845 | £615 | +190.8% ▲ |
| Lidocaine hydrochloride | 27 | 890 | £352 | -84.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.